Spectral Med Inc Asset Resilience Ratio
Spectral Med Inc asset resilience ratio. Spectral Med Inc (EDT) has an Asset Resilience Ratio of 11.67% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Spectral Med Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Spectral Med Inc (2005–2023)
Asset resilience ratio of Spectral Med Inc from 2005 to 2023. This chart shows how Spectral Med Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Spectral Med Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Spectral Med Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Spectral Med Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$608.00K | 11.67% |
| Total Liquid Assets | CA$608.00K | 11.67% |
Asset Resilience Insights
- Moderate Liquidity: Spectral Med Inc has 11.67% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Spectral Med Inc Industry Peers by Asset Resilience Ratio
Compare Spectral Med Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
Diagnostics & Research | 15.15% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Spectral Med Inc Asset Resilience Ratio by Year (2005–2023)
Spectral Med Inc asset resilience ratio by year from 2005 to 2023. The table below shows the annual Asset Resilience Ratio data for Spectral Med Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 11.67% | CA$608.00K ≈ $439.82K |
CA$5.21 Million ≈ $3.77 Million |
+9.66pp |
| 2022-12-31 | 2.01% | CA$241.00K ≈ $174.34K |
CA$12.00 Million ≈ $8.68 Million |
-4.20pp |
| 2021-12-31 | 6.21% | CA$717.00K ≈ $518.67K |
CA$11.55 Million ≈ $8.36 Million |
+3.36pp |
| 2020-12-31 | 2.84% | CA$232.00K ≈ $167.83K |
CA$8.16 Million ≈ $5.90 Million |
+1.24pp |
| 2019-12-31 | 1.60% | CA$64.00K ≈ $46.30K |
CA$4.01 Million ≈ $2.90 Million |
-0.61pp |
| 2018-12-31 | 2.21% | CA$154.00K ≈ $111.40K |
CA$6.98 Million ≈ $5.05 Million |
-40.84pp |
| 2017-12-31 | 43.05% | CA$1.50 Million ≈ $1.08 Million |
CA$3.47 Million ≈ $2.51 Million |
-30.56pp |
| 2016-12-31 | 73.61% | CA$5.23 Million ≈ $3.78 Million |
CA$7.10 Million ≈ $5.14 Million |
+73.12pp |
| 2015-12-31 | 0.48% | CA$41.00K ≈ $29.66K |
CA$8.46 Million ≈ $6.12 Million |
+0.34pp |
| 2014-12-31 | 0.14% | CA$17.00K ≈ $12.30K |
CA$11.86 Million ≈ $8.58 Million |
-0.04pp |
| 2013-12-31 | 0.18% | CA$17.00K ≈ $12.30K |
CA$9.44 Million ≈ $6.83 Million |
-40.64pp |
| 2012-12-31 | 40.82% | CA$5.14 Million ≈ $3.72 Million |
CA$12.59 Million ≈ $9.10 Million |
+16.19pp |
| 2011-12-31 | 24.63% | CA$5.09 Million ≈ $3.68 Million |
CA$20.65 Million ≈ $14.94 Million |
-4.40pp |
| 2010-12-31 | 29.03% | CA$5.02 Million ≈ $3.63 Million |
CA$17.30 Million ≈ $12.51 Million |
-27.43pp |
| 2008-12-31 | 56.46% | CA$4.00 Million ≈ $2.89 Million |
CA$7.08 Million ≈ $5.13 Million |
+2.71pp |
| 2007-12-31 | 53.75% | CA$4.29 Million ≈ $3.10 Million |
CA$7.98 Million ≈ $5.77 Million |
-0.43pp |
| 2006-12-31 | 54.17% | CA$5.06 Million ≈ $3.66 Million |
CA$9.34 Million ≈ $6.75 Million |
+25.19pp |
| 2005-12-31 | 28.98% | CA$3.35 Million ≈ $2.42 Million |
CA$11.56 Million ≈ $8.36 Million |
-- |
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more